Phase
Condition
Depression
Treatment
Placebo
Roflumilast
Fluoxetine
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with age greater than 18 years old.
Patients with Ham-D score at least 18 with item 1 depressed mood scored 2 or greaterare eligible.
Exclusion
Exclusion Criteria:
Patients with bipolar I or bipolar II disorder; eating disorders, personalitydisorders, and mental retardation, current diagnosis anxiety disorders (except forspecific phobia), mental disorder due to general medical condition; met criteria forsubstance dependence or abuse in the previous three months; have a concurrentmedical illness or history of seizures that would contraindicate use of the studymedication and are receiving Electroconvulsive therapy (ECT).
Pregnant women or women not using medically accepted means of birth control areexcluded.
Persons who score greater than 2 on the suicide item of the Ham-D, or who are judgedto have significant suicidal ideation or potential in the view of an investigator,are excluded.
Patients who are required to be free of all psychotropic except for escitalopram andanti-inflammatory medications for at least four weeks before study entry.
Study Design
Connect with a study center
Tanta Unuversity
Tanta, 31527
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.